Literature DB >> 22378780

Silent information regulator 2 (Sir2) and Forkhead box O (FOXO) complement mitochondrial dysfunction and dopaminergic neuron loss in Drosophila PTEN-induced kinase 1 (PINK1) null mutant.

Hyongjong Koh1, Hyunjin Kim, Min Ju Kim, Jeehye Park, Hye-Jeong Lee, Jongkyeong Chung.   

Abstract

PTEN-induced kinase 1 (PINK1), which is associated with early onset Parkinson disease, encodes a serine-threonine kinase that is critical for maintaining mitochondrial function. Moreover, another Parkinson disease-linked gene, parkin, functions downstream of PINK1 in protecting mitochondria and dopaminergic (DA) neuron. In our fly genetic screening, knockdown of Sir2 blocked PINK1 overexpression-induced phenotypes. Consistently, ectopic expression of Sir2 successfully rescued mitochondrial defects in PINK1 null mutants, but unexpectedly, failed in parkin mutants. In further genetic analyses, deletion of FOXO nullified the Sir2-induced mitochondrial restoration in PINK1 null mutants. Moreover, overexpression of FOXO or its downstream target gene such as SOD2 or Thor markedly ameliorated PINK1 loss-of-function defects, suggesting that FOXO mediates the mitochondrial protecting signal induced by Sir2. Consistent with its mitochondria-protecting role, Sir2 expression prevented the DA neuron loss of PINK1 null mutants in a FOXO-dependent manner. Loss of Sir2 or FOXO induced DA neuron degeneration, which is very similar to that of PINK1 null mutants. Furthermore, PINK1 deletion had no deleterious effect on the DA neuron loss in Sir2 or FOXO mutants, supporting the idea that Sir2, FOXO, and PINK1 protect DA neuron in a common pathway. Overall, these results strongly support the role of Sir2 and FOXO in preventing mitochondrial dysfunction and DA neuron loss, further suggesting that Sir2 and FOXO function downstream of PINK1 and independently of Parkin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378780      PMCID: PMC3339960          DOI: 10.1074/jbc.M111.337907

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.

Authors:  Y Imai; M Soda; R Takahashi
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

Review 2.  FoxOs at the crossroads of cellular metabolism, differentiation, and transformation.

Authors:  Domenico Accili; Karen C Arden
Journal:  Cell       Date:  2004-05-14       Impact factor: 41.582

3.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

4.  Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress.

Authors:  Geert J P L Kops; Tobias B Dansen; Paulien E Polderman; Ingrid Saarloos; Karel W A Wirtz; Paul J Coffer; Ting-T Huang; Johannes L Bos; René H Medema; Boudewijn M T Burgering
Journal:  Nature       Date:  2002-09-19       Impact factor: 49.962

5.  Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.

Authors:  Jessica C Greene; Alexander J Whitworth; Isabella Kuo; Laurie A Andrews; Mel B Feany; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

6.  Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.

Authors:  Anne Brunet; Lora B Sweeney; J Fitzhugh Sturgill; Katrin F Chua; Paul L Greer; Yingxi Lin; Hien Tran; Sarah E Ross; Raul Mostoslavsky; Haim Y Cohen; Linda S Hu; Hwei-Ling Cheng; Mark P Jedrychowski; Steven P Gygi; David A Sinclair; Frederick W Alt; Michael E Greenberg
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

7.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

8.  Control of cell number by Drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway.

Authors:  Oscar Puig; Michael T Marr; M Laure Ruhf; Robert Tjian
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

9.  The loss of PGAM5 suppresses the mitochondrial degeneration caused by inactivation of PINK1 in Drosophila.

Authors:  Yuzuru Imai; Tomoko Kanao; Tomoyo Sawada; Yoshito Kobayashi; Yasuhiro Moriwaki; Yosuke Ishida; Kohsuke Takeda; Hidenori Ichijo; Bingwei Lu; Ryosuke Takahashi
Journal:  PLoS Genet       Date:  2010-12-02       Impact factor: 5.917

10.  Hereditary early-onset Parkinson's disease caused by mutations in PINK1.

Authors:  Enza Maria Valente; Patrick M Abou-Sleiman; Viviana Caputo; Miratul M K Muqit; Kirsten Harvey; Suzana Gispert; Zeeshan Ali; Domenico Del Turco; Anna Rita Bentivoglio; Daniel G Healy; Alberto Albanese; Robert Nussbaum; Rafael González-Maldonado; Thomas Deller; Sergio Salvi; Pietro Cortelli; William P Gilks; David S Latchman; Robert J Harvey; Bruno Dallapiccola; Georg Auburger; Nicholas W Wood
Journal:  Science       Date:  2004-04-15       Impact factor: 47.728

View more
  26 in total

Review 1.  PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity.

Authors:  Hyongjong Koh; Jongkyeong Chung
Journal:  Mol Cells       Date:  2012-05-18       Impact factor: 5.034

2.  The Organization of Mitochondrial Quality Control and Life Cycle in the Nervous System In Vivo in the Absence of PINK1.

Authors:  Swathi Devireddy; Alex Liu; Taylor Lampe; Peter J Hollenbeck
Journal:  J Neurosci       Date:  2015-06-24       Impact factor: 6.167

Review 3.  FOXO transcription factors: key regulators of cellular quality control.

Authors:  Ashley E Webb; Anne Brunet
Journal:  Trends Biochem Sci       Date:  2014-03-13       Impact factor: 13.807

Review 4.  Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.

Authors:  Ming Guo
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

Review 5.  Role of FOXO transcription factors in crosstalk between mitochondria and the nucleus.

Authors:  Sujin Kim; Hyongjong Koh
Journal:  J Bioenerg Biomembr       Date:  2017-08       Impact factor: 2.945

6.  Fat body dSir2 regulates muscle mitochondrial physiology and energy homeostasis nonautonomously and mimics the autonomous functions of dSir2 in muscles.

Authors:  Kushal K Banerjee; Champakali Ayyub; Samudra Sengupta; Ullas Kolthur-Seetharam
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

7.  Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria.

Authors:  Hyunjin Kim; Jinsung Yang; Min Ju Kim; Sekyu Choi; Ju-Ryung Chung; Jong-Min Kim; Young Hyun Yoo; Jongkyeong Chung; Hyongjong Koh
Journal:  J Biol Chem       Date:  2015-12-02       Impact factor: 5.157

Review 8.  SOD2 in mitochondrial dysfunction and neurodegeneration.

Authors:  James M Flynn; Simon Melov
Journal:  Free Radic Biol Med       Date:  2013-05-29       Impact factor: 7.376

Review 9.  Keeping Neurons Young and Foxy: FoxOs Promote Neuronal Plasticity.

Authors:  Colleen N McLaughlin; Heather T Broihier
Journal:  Trends Genet       Date:  2018-01       Impact factor: 11.639

10.  Characterization of PINK1 (PTEN-induced putative kinase 1) mutations associated with Parkinson disease in mammalian cells and Drosophila.

Authors:  Saera Song; Seoyeon Jang; Jeehye Park; Sunhoe Bang; Sekyu Choi; Kyum-Yil Kwon; Xiaoxi Zhuang; Eunjoon Kim; Jongkyeong Chung
Journal:  J Biol Chem       Date:  2013-01-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.